PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 600.0
(-0.83%)
IDR 600.0
(-0.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1570.24 Billion IDR | -379.87% |
| 2022 | 558.07 Billion IDR | -43.38% |
| 2021 | 985.63 Billion IDR | 50.93% |
| 2020 | 653.02 Billion IDR | 30.17% |
| 2019 | 501.65 Billion IDR | -34.43% |
| 2018 | 765.01 Billion IDR | 42.82% |
| 2017 | 535.66 Billion IDR | 20.96% |
| 2016 | 442.82 Billion IDR | 18.31% |
| 2015 | 374.27 Billion IDR | 9.28% |
| 2014 | 342.48 Billion IDR | 16.58% |
| 2013 | 293.76 Billion IDR | 3.02% |
| 2012 | 285.15 Billion IDR | 28.45% |
| 2011 | 222 Billion IDR | 51.85% |
| 2010 | 146.19 Billion IDR | 30.61% |
| 2009 | 111.93 Billion IDR | 4.57% |
| 2008 | 107.03 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -20.95 Billion IDR | 98.7% |
| 2024 Q3 | -136.03 Billion IDR | -236.31% |
| 2024 Q2 | -40.45 Billion IDR | -93.08% |
| 2023 Q4 | -1608.45 Billion IDR | -37639.09% |
| 2023 Q1 | 120.8 Billion IDR | -71.35% |
| 2023 FY | -1561.88 Billion IDR | -379.87% |
| 2023 Q2 | 115.48 Billion IDR | -4.4% |
| 2023 Q3 | 4.28 Billion IDR | -96.29% |
| 2022 Q3 | 152.07 Billion IDR | 217.39% |
| 2022 FY | 558.07 Billion IDR | -43.38% |
| 2022 Q4 | 421.66 Billion IDR | 177.27% |
| 2022 Q2 | -129.54 Billion IDR | -212.47% |
| 2022 Q1 | 115.18 Billion IDR | -28.21% |
| 2021 Q1 | 156.28 Billion IDR | 5.25% |
| 2021 Q4 | 160.43 Billion IDR | -65.68% |
| 2021 FY | 985.63 Billion IDR | 50.93% |
| 2021 Q3 | 467.44 Billion IDR | 132.02% |
| 2021 Q2 | 201.47 Billion IDR | 28.92% |
| 2020 Q1 | 160.83 Billion IDR | 121.82% |
| 2020 FY | 653.02 Billion IDR | 30.17% |
| 2020 Q2 | 204.19 Billion IDR | 26.96% |
| 2020 Q3 | 139.5 Billion IDR | -31.68% |
| 2020 Q4 | 148.48 Billion IDR | 6.44% |
| 2019 Q4 | 72.5 Billion IDR | -45.42% |
| 2019 Q1 | 108.92 Billion IDR | -61.33% |
| 2019 Q2 | 187.37 Billion IDR | 72.01% |
| 2019 Q3 | 132.84 Billion IDR | -29.1% |
| 2019 FY | 501.65 Billion IDR | -34.43% |
| 2018 Q4 | 281.72 Billion IDR | 40.17% |
| 2018 Q2 | 155.54 Billion IDR | 22.7% |
| 2018 Q1 | 126.76 Billion IDR | -37.57% |
| 2018 FY | 765.01 Billion IDR | 42.82% |
| 2018 Q3 | 200.98 Billion IDR | 29.22% |
| 2017 Q3 | 158.04 Billion IDR | 40.41% |
| 2017 Q4 | 203.05 Billion IDR | 28.48% |
| 2017 Q2 | 112.56 Billion IDR | 81.57% |
| 2017 Q1 | 61.99 Billion IDR | -62.73% |
| 2017 FY | 535.66 Billion IDR | 20.96% |
| 2016 Q2 | 85.14 Billion IDR | 25.87% |
| 2016 FY | 442.82 Billion IDR | 18.31% |
| 2016 Q4 | 166.33 Billion IDR | 34.48% |
| 2016 Q1 | 67.64 Billion IDR | -45.22% |
| 2016 Q3 | 123.69 Billion IDR | 45.27% |
| 2015 Q3 | 125.03 Billion IDR | 129.59% |
| 2015 FY | 374.27 Billion IDR | 9.28% |
| 2015 Q1 | 71.29 Billion IDR | -44.6% |
| 2015 Q2 | 54.45 Billion IDR | -23.61% |
| 2015 Q4 | 123.49 Billion IDR | -1.23% |
| 2014 Q4 | 128.67 Billion IDR | 12.01% |
| 2014 FY | 342.48 Billion IDR | 16.58% |
| 2014 Q1 | 29.6 Billion IDR | -75.96% |
| 2014 Q3 | 114.87 Billion IDR | 65.72% |
| 2014 Q2 | 69.32 Billion IDR | 134.17% |
| 2013 Q1 | 30.3 Billion IDR | -55.62% |
| 2013 Q3 | 111.15 Billion IDR | 280.83% |
| 2013 Q4 | 123.11 Billion IDR | 10.76% |
| 2013 FY | 293.76 Billion IDR | 3.02% |
| 2013 Q2 | 29.18 Billion IDR | -3.68% |
| 2012 Q3 | 95.14 Billion IDR | 18.58% |
| 2012 Q4 | 68.27 Billion IDR | -28.24% |
| 2012 Q1 | 41.5 Billion IDR | 8.75% |
| 2012 Q2 | 80.23 Billion IDR | 93.32% |
| 2012 FY | 285.15 Billion IDR | 28.45% |
| 2011 Q2 | 32.79 Billion IDR | 5.67% |
| 2011 Q3 | 120.01 Billion IDR | 266.01% |
| 2011 Q4 | 38.16 Billion IDR | -68.2% |
| 2011 FY | 222 Billion IDR | 51.85% |
| 2011 Q1 | 31.03 Billion IDR | 0.0% |
| 2010 FY | 146.19 Billion IDR | 30.61% |
| 2009 FY | 111.93 Billion IDR | 4.57% |
| 2008 FY | 107.03 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 872.14 Billion IDR | 280.045% |
| PT Itama Ranoraya Tbk | 26.79 Billion IDR | 5960.326% |
| PT Millennium Pharmacon International Tbk | 105.39 Billion IDR | 1589.832% |
| PT Soho Global Health Tbk | 438.67 Billion IDR | 457.956% |